D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats

被引:45
作者
Esneault, E. [1 ,2 ]
Castagne, V. [1 ]
Moser, P. [1 ]
Bonny, C. [3 ]
Bernalidin, M. [2 ]
机构
[1] Porsolt & Partners Pharmacol, ZA Suhards, F-53940 Le Genest St Isle, France
[2] Univ Caen, CNRS, CERVOxy Grp Hypoxia & Cerebrovasc Pathophysiol, CYCERON,UMR 6185, F-14074 Caen, France
[3] CHU Vaudois, Univ Hosp, Div Med Genet, CH-1011 Lausanne, Switzerland
关键词
JNK; behavior; neurological score; adhesive removal test; object recognition; beam walking test;
D O I
10.1016/j.neuroscience.2007.12.036
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The c-Jun-N-terminal kinase (JNK) pathway has been shown to play an important role in excitotoxic neuronal death and several studies have demonstrated a neuroprotective effect of D-JNKi, a peptide inhibitor of JNK, in various models of cerebral ischemia. We have now investigated the effect of D-JNKi in a model of transient focal cerebral ischemia (90 min) induced by middle cerebral artery occlusion (MCAo) in adult male rats. D-JNKi (0.1 mg/kg), significantly decreased the volume of infarct, 3 days after cerebral ischemia. Sensorimotor and cognitive deficits were then evaluated over a period of 6 or 10 days after ischemia and infarct volumes were measured after behavioral testing. In behavioral studies, D-JNKi improved the general state of the animals as demonstrated by the attenuation of body weight loss and improvement in neurological score, as compared with animals receiving the vehicle. Moreover, D-JNKi decreased sensorimotor deficits in the adhesive removal test and improved cognitive function in the object recognition test. In contrast, D-JNKi did not significantly affect the infarct volume at day 6 and at day 10. This study shows that D-JNKi can improve functional recovery after transient focal cerebral ischemia in the rat and therefore supports the use of this molecule as a potential therapy for stroke. (C) 2008 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:308 / 320
页数:13
相关论文
共 65 条
[1]   Behavioral and neuroplastic effects of focal endothelin-1 induced sensorimotor cortex lesions [J].
Adkins, DL ;
Voorhies, AC ;
Jones, TA .
NEUROSCIENCE, 2004, 128 (03) :473-486
[2]   Recognition memory for objects, place, and temporal order: A disconnection analysis of the role of the medial prefrontal cortex and perirhinal cortex [J].
Barker, Gareth R. I. ;
Bird, Flora ;
Alexander, Victoria ;
Warburton, E. Clea .
JOURNAL OF NEUROSCIENCE, 2007, 27 (11) :2948-2957
[3]   Identification of the critical features of a small peptide inhibitor of JNK activity [J].
Barr, RK ;
Kendrick, TS ;
Bogoyevitch, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :10987-10997
[4]   RAT MIDDLE CEREBRAL-ARTERY OCCLUSION - EVALUATION OF THE MODEL AND DEVELOPMENT OF A NEUROLOGIC EXAMINATION [J].
BEDERSON, JB ;
PITTS, LH ;
TSUJI, M ;
NISHIMURA, MC ;
DAVIS, RL ;
BARTKOWSKI, H .
STROKE, 1986, 17 (03) :472-476
[5]   Enriched rehabilitative training promotes improved forelimb motor function and enhanced dendritic growth after focal ischemic injury [J].
Biernaskie, J ;
Corbett, D .
JOURNAL OF NEUROSCIENCE, 2001, 21 (14) :5272-5280
[6]   Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential [J].
Bogoyevitch, MA ;
Boehm, I ;
Oakley, A ;
Ketteman, AJ ;
Barr, RK .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :89-101
[7]   Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death [J].
Bonny, C ;
Oberson, A ;
Negri, S ;
Sauser, C ;
Schorderet, DF .
DIABETES, 2001, 50 (01) :77-82
[8]   A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia [J].
Borsello, T ;
Clarke, PGH ;
Hirt, L ;
Vercelli, A ;
Repici, M ;
Schorderet, DF ;
Bogousslavsky, J ;
Bonny, C .
NATURE MEDICINE, 2003, 9 (09) :1180-1186
[9]   Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease [J].
Bozyczko-Coyne, Donna ;
Saporito, Michael S. ;
Hudkins, Robert L. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (01) :31-49
[10]   Treatment of acute stroke - Still struggling [J].
Caplan, LR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (15) :1883-1885